Obesity Medicine

Obesity medication is the field of pharmaceutical devoted to the far-reaching consideration of patients with obese. It is the field of medicine committed to the absolute care of patients with obesityObesity Medicine target on health and disease, relating to the very broad spectrum of research in and strike on humans.Obesity medicine clinicians who are individuals from the Obesity Medicine Association   use an exhaustive, logical, and individualized approach involved nutrition, physical activity, conduct treatment, and prescription to enable patients to get more fit and accomplish better general health.

  • Contrave (naltrexone HCl and bupropion HCl) ; Takeda Pharmaceuticals U.S.A.; For chronic weight management , Approved September 2014
  • Jardiance (empagliflozin) ; Boehringer Ingelheim; For the treatment of type II diabetes, Approved August 2014
  • Saxenda (liraglutide [rDNA origin] injection); Novo Nordisk; For chronic weight management, Approved December 2014
  • Tanzeum (albiglutide); GlaxoSmithKline; For the treatment of type II diabetes mellitus, Approved April 2014
  • Trulicity (dulaglutide); Eli Lilly; To improve glycemic control in type II diabetics, Approved September 2014
  • Nesina (alogliptin); Takeda; For the treatment of type II diabetes mellitus, Approved January 2013
  • Belviq (lorcaserin hydrochloride); Arena Pharmaceuticals; For the chronic management of weight loss, Approved June 2012
  • Bydureon (exenatide extended-release for injectable suspension); Amylin; For the improvement of glycemic control in adults with type II diabetes mellitus, Approved January 2012
  • Qsymia (phentermine + topiramate extended-release); Vivus; For the treatment of chronic weight management, Approved July 2012

Related Conference of Obesity Medicine

January 18-19, 2021

Global summit on Obesity, Diet and Nutrition

London, Aland Islands
April 06-07, 2021

21st World Congress on Obesity and Metabolic Diseases

Manila, Philippines
June 23-24, 2021

World Obesity and Weight Management Congress

Rome, Italy
July 05-06, 2021

17th Euro Obesity and Endocrinology Congress

Valencia, Spain
September 02-03, 2021

23rd Annual Meet on Obesity and Diet

Vienna, Austria
December 13-14, 2021

4th Middle East Obesity, Bariatric Surgery and Endocrinology Congress

Prague, Czech Republic

Obesity Medicine Conference Speakers

Recommended Sessions

Related Journals

Are you interested in